FDA approves new drug Rasonque to treat advanced pancreatic cancer
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.
We haven't written up this one. France 24 has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA biopharmadive.com
- FDA approves new pancreatic cancer drug after trial doubles patient survival israelnationalnews.com
